15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Clearpoint Neuro Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $30.00 to $30.00, so the covering firms are broadly aligned. The average target of $30.00 sits 116% above the current $13.90. The rating mix has stayed broadly stable, with Buy-side ratings easing from 2 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.29 next quarter toward $-1.20 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Clearpoint Neuro Inc.
As of Sep, 1 of 1 firms rate CLPT a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CLPT EPS & revenue forecast
EPS · NEXT QUARTER
$-0.29
Range $-0.34 – $-0.25 · 2 analysts · +9% YoY
Next period, 2 analysts expect Clearpoint Neuro Inc to earn $-0.29 a share (range $-0.34 – $-0.25), versus $-0.27 a year earlier. Full-year consensus is $-1.30, growing to $-1.20 the year after.
REVENUE · NEXT QUARTER
$13.7M
Range $12.9M – $14.4M · 2 analysts · +31% YoY
Revenue is expected to reach $13.7M (range $12.9M – $14.4M), +31.1% year-over-year. Full-year consensus is $49.0M, rising to $56.5M next year.
Top analysts covering Clearpoint Neuro Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CLPT.
#1
Frank Takkinen
Lake Street · Rank #394
Buy
$30.00+115.8% to target
Overall win rate
26%
+ Follow
#2
NC
Neil Chatterji
B. Riley Securities
Buy
$20.00+43.9% to target
Coverage
—
+ Follow
#3
AS
Anderson Schock
B. Riley Securities
Buy
$30.00+115.8% to target
Coverage
—
+ Follow
#4
MB
Mathew Blackman
Stifel
Buy
$25.00+79.9% to target
Coverage
—
+ Follow
CLPT stock forecast FAQ
What is CLPT's average 12-month price target?+
The 1 analysts with a live target average $30.00 for Clearpoint Neuro Inc over the next 12 months, ranging from a $30.00 high to a $30.00 low.
Is CLPT stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover CLPT?+
1 analysts have an active rating on Clearpoint Neuro Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering CLPT?+
Among analysts who currently cover CLPT, Frank Takkinen of Lake Street has the strongest overall Quantellect track record (Rank #394). Their current call is Buy with a $30.00 target.
What is Clearpoint Neuro Inc's projected EPS for next quarter?+
The consensus estimate is $-0.29 per share (range $-0.34 – $-0.25) across 2 analysts. Full-year EPS is projected at $-1.30, rising to $-1.20 the following year.
How much revenue is Clearpoint Neuro Inc expected to report next quarter?+
Consensus revenue is $13.7M (range $12.9M – $14.4M). Full-year revenue is projected at $49.0M, growing to $56.5M next year.
Have analysts been upgrading or downgrading CLPT lately?+
As of Sep, 1 of 1 firms rate CLPT a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CLPT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
